hodgkin lymphoma
Showing NaN - NaN of 8
Ovarian Reserve in Younger Newly Diagnosed Lymphomas
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
- Laboratory Biomarker Analysis
- Questionnaire Administration
-
Birmingham, Alabama
- +106 more
Jan 11, 2023
Hodgkin Lymphoma, Peripheral T Cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in United States (brentuximab vedotin)
Terminated
- Hodgkin Lymphoma
- +2 more
- brentuximab vedotin
-
Anaheim, California
- +18 more
Dec 6, 2022
Hodgkin Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin, vinblastine)
Active, not recruiting
- Hodgkin Lymphoma
- brentuximab vedotin
- +5 more
-
Fountain Valley, California
- +75 more
Dec 2, 2022
Participated in Children's Oncology Group Studies
Recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- Assessment of Therapy Complications
- Questionnaire Administration
-
Birmingham, Alabama
- +163 more
Sep 6, 2022
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
-
Birmingham, Alabama
- +38 more
Nov 2, 2021
Hodgkin Lymphoma Trial in United States (brentuximab vedotin, nivolumab)
Hodgkin Lymphoma Trial in United States (Everolimus (RAD001))
Completed
- Hodgkin Lymphoma
- Everolimus (RAD001)
-
Los Angeles, California
- +15 more
Apr 18, 2016